Skip to Content

P-5377

Main Content

Blood | 2020

Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR-T cell era?

Shah NN, Ahn KW, Litovich C, He Y, Sauter CS, Fenske TS, Hamadani M

PubMed
PMID: 33120429

Abstract
Related Articles

CIBMTR Study #: LY18-01b

Working Committee: Lymphoma